CISMM inventions have been commercialized by Redbud Labs, a vendor of microfluidic chips designed to improve point-of-care molecular diagnostics. The company licensed biomimetic cilia technology developed as part of the Virtual Lung Project. CISMM research demonstrated that magnetically actuated micro-rods could simultaneously pump and mix fluids at the microscale. Redbud Labs built on this discovery to develop a microfluidic mixing chip called MXR. This microfluidic mixer is used by molecular diagnostics companies to enable faster microarray assays.